Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA® and OTX-TIC in Asia
Ocular Therapeutix to receive $12 million upfront fee and development and commercialization milestones and other…
Ocular Therapeutix to receive $12 million upfront fee and development and commercialization milestones and other…
Activities will support the clinical development of Rugen’s potential first-in-class, orally administered drug candidate with…
Xiaomi takes third spot; realme grows fastest at 132% QoQ NEW DELHI & HONG KONG…
Adventure Travel Brand Recognized as Silver Winner for Overall River Cruising and Overall Destinations AUGUSTA,…
BEIJING--(BUSINESS WIRE)--The 2021 Chinese Xin Chou Year (Year of the Ox) Gold and Silver Commemorative…
HO CHI MINH CITY, VIETNAM - Media OutReach - 30 October, 2020 - The HCM…
SHANGHAI--(BUSINESS WIRE)--Lufax Holding Ltd (“Lufax” or the “Company”), a leading technology-empowered personal financial services platform…
TAIPEI, Taiwan--(BUSINESS WIRE)--Three years after its foundation in 2017, the Taiwan Cultural Memory Bank launched…
TAIPEI, Taiwan--(BUSINESS WIRE)--Three years after its foundation in 2017, the Taiwan Cultural Memory Bank launched…
HONG KONG, CHINA - Media OutReach - 30 October 2020 - DFA Awards 2020 is pleased to announce…